Search results
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain:...
Simply Wall St. via Yahoo Finance· 5 months agoMost readers would already know that Supernus Pharmaceuticals' (NASDAQ:SUPN) stock increased by 9.4%...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript November 8, 2023...
Insider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ...
GuruFocus.com via Yahoo Finance· 7 months agoSupernus Pharmaceuticals Inc (NASDAQ:SUPN), a biopharmaceutical company focused on developing and...
Q4 2023 Supernus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Jack Khattar; President, Chief Executive Officer, Secretary, Director; Supernus Pharmaceuticals Inc Timothy Dec; Chief Financial Officer, Senior Vice President; Supernus Pharmaceuticals ...
Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
GuruFocus.com via Yahoo Finance· 1 month agoTotal Revenue: Reported at $143.6 million, falling short of the estimated $145.83 million. Net Income: Reached $0.1 million, significantly below the estimated $20.73 million. Earnings Per Share ...